Second-line option for metastatic RCC

被引：0
|
作者：
Vanessa Marchesi
机构：
来源：
Nature Reviews Clinical Oncology | 2013年 / 10卷 / 6期
关键词：
D O I：
10.1038/nrclinonc.2013.74
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：305 / 305
相关论文
共 50 条
  • [41] Not only chemotherapy in the second-line treatment of metastatic gastric cancer
    Vasile, E.
    Caparello, C.
    Caponi, S.
    Ginocchi, L.
    Vivaldi, C.
    Musettini, G.
    Lucchesi, M.
    Lencioni, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 544 - 545
  • [42] Treatment Choices for Second-Line Chemotherapy of Metastatic Breast Cancer
    Christoph C. Zielinski
    Breast Cancer Research and Treatment, 2003, 81 (Suppl 1) : 33 - 36
  • [43] The Efficacy of Second-line Chemotherapy for Advanced or Metastatic Urothelial Cancer
    Naito, Renato
    Izumi, Kouji
    Kadomoto, Suguru
    Makino, Tomoyuki
    Iwamoto, Hiroaki
    Yaegashi, Hiroshi
    Shigehara, Kazuyoshi
    Kadono, Yoshifumi
    Mizokami, Atsushi
    ANTICANCER RESEARCH, 2020, 40 (02) : 1141 - 1146
  • [44] Second-line chemotherapy for metastatic/recurrent head and neck cancer
    Ferrari, D.
    Codeca, C.
    Caldiera, S.
    Zonato, S.
    Luciani, A.
    Fiore, J.
    Cossu-Rocca, M.
    Verri, E.
    Foa, P.
    ANNALS OF ONCOLOGY, 2007, 18 : 56 - 56
  • [45] Sequencing Beyond the Second-Line Setting in Metastatic Colorectal Cancer
    Grothey, Axel
    Marshall, John L.
    Bekaii-Saab, Tanios
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (03)
  • [46] Management of metastatic colorectal cancer and indications of second-line chemotherapy
    Rougier, PP
    PRESSE MEDICALE, 1996, 25 (22): : 1004 - 1005
  • [47] Outcomes with second-line chemotherapy in castrate metastatic prostate cancer
    Beekman, KW
    Fleming, MT
    Scher, HI
    Warren, M
    Ishill, N
    Heller, G
    Kelly, WK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 417S - 417S
  • [48] Ramucirumab as second-line treatment for patients with metastatic esophagogastric adenocarcinoma
    Hofheinz, Ralf-Dieter
    Lorenzen, Sylvie
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (06) : 607 - 614
  • [49] Taxotere as second-line chemotherapy for metastatic breast cancer.
    Culine, S
    REVUE DE MEDECINE INTERNE, 1999, 20 (03): : 277 - 280
  • [50] Survival predictors in second-line chemotherapy for metastatic gastric cancer
    Bohanes, P. O.
    Courvoisier, D.
    Perneger, T.
    Morel, P.
    Huber, O.
    Roth, A. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345